These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32991138)

  • 1. Biochemical Characterization of Mouse Retina of an Alzheimer's Disease Model by Raman Spectroscopy.
    Stiebing C; Jahn IJ; Schmitt M; Keijzer N; Kleemann R; Kiliaan AJ; Drexler W; Leitgeb RA; Popp J
    ACS Chem Neurosci; 2020 Oct; 11(20):3301-3308. PubMed ID: 32991138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of Proteolytic Pathways and Altered Protein Biosynthesis Underlie Retinal Pathology in a Mouse Model of Alzheimer's Disease.
    Mirzaei M; Pushpitha K; Deng L; Chitranshi N; Gupta V; Rajput R; Mangani AB; Dheer Y; Godinez A; McKay MJ; Kamath K; Pascovici D; Wu JX; Salekdeh GH; Karl T; Haynes PA; Graham SL; Gupta VK
    Mol Neurobiol; 2019 Sep; 56(9):6017-6034. PubMed ID: 30707393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse.
    Gupta VK; Chitranshi N; Gupta VB; Golzan M; Dheer Y; Wall RV; Georgevsky D; King AE; Vickers JC; Chung R; Graham S
    Neurosci Lett; 2016 Jun; 623():52-6. PubMed ID: 27133194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations into Retinal Pathology in the Early Stages of a Mouse Model of Alzheimer's Disease.
    Chidlow G; Wood JP; Manavis J; Finnie J; Casson RJ
    J Alzheimers Dis; 2017; 56(2):655-675. PubMed ID: 28035930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperspectral imaging signatures detect amyloidopathy in Alzheimer's mouse retina well before onset of cognitive decline.
    More SS; Vince R
    ACS Chem Neurosci; 2015 Feb; 6(2):306-15. PubMed ID: 25354367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease.
    Klakotskaia D; Agca C; Richardson RA; Stopa EG; Schachtman TR; Agca Y
    PLoS One; 2018; 13(4):e0195469. PubMed ID: 29641600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease.
    Sadleir KR; Popovic J; Vassar R
    J Biol Chem; 2018 Nov; 293(48):18434-18443. PubMed ID: 30315100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrosylation of Vesicular Transporters in Brain of Amyloid Precursor Protein/Presenilin 1 Double Transgenic Mice.
    Wang Y; Zhou Z; Tan H; Zhu S; Wang Y; Sun Y; Li XM; Wang JF
    J Alzheimers Dis; 2017; 55(4):1683-1692. PubMed ID: 27911305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease.
    Zhu S; Wang J; Zhang Y; He J; Kong J; Wang JF; Li XM
    CNS Neurosci Ther; 2017 Apr; 23(4):310-320. PubMed ID: 28191738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo.
    Gandy S; Zhang YW; Ikin A; Schmidt SD; Bogush A; Levy E; Sheffield R; Nixon RA; Liao FF; Mathews PM; Xu H; Ehrlich ME
    J Neurochem; 2007 Aug; 102(3):619-26. PubMed ID: 17630980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.
    Allué JA; Sarasa L; Izco M; Pérez-Grijalba V; Fandos N; Pascual-Lucas M; Ogueta S; Pesini P; Sarasa M
    J Alzheimers Dis; 2016 May; 53(3):773-85. PubMed ID: 27258422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.